If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro ® (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can Mounjaro® (tirzepatide) be used in adults with COVID-19?
The use of tirzepatide in patients with COVID-19 has not been studied.
See important safety information, including boxed warning, in the attached prescribing information.
Use in Adults With COVID-19
Coronavirus disease (COVID-19) is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously referred to as "2019 novel coronavirus."1
While some people may have had COVID-19 during their participation in tirzepatide trials, Eli Lilly and Company (Lilly) has not studied its use in adults with COVID-19 nor in adults at risk of contracting COVID-19.
Clinicians should use their clinical judgment in determining the most appropriate approach in treating a patient with tirzepatide who has confirmed or suspected COVID-19.
Infectious Disease Resources for COVID-19
For current information on COVID-19, please refer to
- coronavirus disease (COVID-19) pandemic on the World Health Organization website, and
- COVID-19 on the Centers for Disease Control and Prevention website.2,3
Enclosed Prescribing Information
References
1Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization. Accessed August 10, 2023. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
2Coronavirus disease (COVID-19) pandemic. World Health Organization. Accessed November 9, 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
3COVID-19. Centers for Disease Control and Prevention. Accessed November 9, 2021. https://www.cdc.gov/coronavirus/2019-ncov/index.html
Date of Last Review: January 09, 2024